Loxo Oncology

YTD

ALL

Why Robinhood?

You can watch Loxo Oncology and buy or sell other stocks, ETFs, and their options commission-free!

About LOXO

Loxo Oncology was incorporated in Delaware in May 2013 and was founded by Josh Bilenker, M.D., a partner at Aisling Capital. Loxo Oncology is committed to bringing targeted cancer therapies rapidly into the clinic that have an opportunity for outsized clinical effects in genetically defined patient populations.

CEO

Jacob S. van Naarden

CEOJacob S. van Naarden

Employees

—

Employees—

Headquarters

Stamford, Connecticut

HeadquartersStamford, Connecticut

Founded

2013

Founded2013

Employees

—

Employees—

LOXO Key Statistics

Market cap

7.17B

Market cap7.17B

Price-Earnings ratio

-112.57

Price-Earnings ratio-112.57

Dividend yield

—

Dividend yield—

Average volume

479.60K

Average volume479.60K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$234.93

52 Week high$234.93

52 Week low

$103.50

52 Week low$103.50